125 related articles for article (PubMed ID: 36226401)
1. Neurofibromatosis type 1: Factors associated with flare-ups of cutaneous neurofibromas at puberty.
Skayem C; Fertitta L; Diaz E; Jannic A; Ferkal S; Ravaud P; Tran VT; Ezzedine K; Wolkenstein P
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):e158-e159. PubMed ID: 36226401
[No Abstract] [Full Text] [Related]
2. Pilot study for the treatment of cutaneous neurofibromas in neurofibromatosis type 1 patients using topical sirolimus gel.
Wataya-Kaneda M; Watanabe Y; Nakamura A; Yamamoto K; Okada K; Maeda S; Nimura K; Saga K; Katayama I
J Am Acad Dermatol; 2023 Apr; 88(4):877-880. PubMed ID: 36334988
[No Abstract] [Full Text] [Related]
3. Melanocytic nevi are associated with neurofibromas in neurofibromatosis, type I, but not sporadic neurofibromas: a study of 226 cases.
Ball NJ; Kho GT
J Cutan Pathol; 2005 Sep; 32(8):523-32. PubMed ID: 16115049
[TBL] [Abstract][Full Text] [Related]
4. Outcomes that need to be assessed in clinical trials for cutaneous neurofibromas in people with neurofibromatosis type 1.
Br J Dermatol; 2024 Jan; 190(2):e20. PubMed ID: 38262593
[No Abstract] [Full Text] [Related]
5. Cutaneous neurofibromas: Current clinical and pathologic issues.
Ortonne N; Wolkenstein P; Blakeley JO; Korf B; Plotkin SR; Riccardi VM; Miller DC; Huson S; Peltonen J; Rosenberg A; Carroll SL; Verma SK; Mautner V; Upadhyaya M; Stemmer-Rachamimov A
Neurology; 2018 Jul; 91(2 Suppl 1):S5-S13. PubMed ID: 29987130
[TBL] [Abstract][Full Text] [Related]
6. Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1.
Maguiness S; Berman Y; Rubin N; Dodds M; Plotkin SR; Wong C; Moertel C;
Neurology; 2021 Aug; 97(7 Suppl 1):S25-S31. PubMed ID: 34230204
[TBL] [Abstract][Full Text] [Related]
7. How to score the impact of treatment on cutaneous neurofibromas in clinical trials.
Ortonne N
Br J Dermatol; 2024 Jan; 190(2):147-148. PubMed ID: 38084905
[No Abstract] [Full Text] [Related]
8. A Call for Discovery and Therapeutic Development for Cutaneous Neurofibromas.
Blakeley JO; Le LQ; Lee SY; Ly I; Rhodes SD; Romo CG; Sarin KY; Staedtke V; Steensma MR; Wolkenstein P;
J Invest Dermatol; 2023 Aug; 143(8):1351-1357. PubMed ID: 37354152
[No Abstract] [Full Text] [Related]
9. [Recklinhausen's phacomatosis with neurofibroma in an unusual location].
Unger C
Przegl Dermatol; 1966; 53(6):697-703. PubMed ID: 4962789
[No Abstract] [Full Text] [Related]
10. Superficial malignant peripheral nerve sheath tumor arising from diffuse neurofibroma in a neurofibromatosis type 1 patient.
Inoue T; Kuwashiro M; Misago N; Narisawa Y
J Dermatol; 2014 Jul; 41(7):631-3. PubMed ID: 24942776
[TBL] [Abstract][Full Text] [Related]
11. Neurofibroma of the recurrent laryngeal nerve.
Rees G
Chest; 1971 Oct; 60(4):414-8. PubMed ID: 5000534
[No Abstract] [Full Text] [Related]
12. Floret-like multinucleated giant cells in a neurofibromatosis type 1-associated neurofibroma.
Swick BL
Am J Dermatopathol; 2008 Dec; 30(6):632-4. PubMed ID: 19033946
[TBL] [Abstract][Full Text] [Related]
13. Neurofibroma of the larynx occurring with Von Recklinghausen disease. Report of a case.
Jafek BW; Stern FA
Arch Otolaryngol; 1973 Aug; 98(2):77-9. PubMed ID: 4198850
[No Abstract] [Full Text] [Related]
14. At-risk phenotype of neurofibromatose-1 patients: a multicentre case-control study.
Sbidian E; Bastuji-Garin S; Valeyrie-Allanore L; Ferkal S; Lefaucheur JP; Drouet A; Brugière P; Vialette C; Combemale P; Barbarot S; Wolkenstein P;
Orphanet J Rare Dis; 2011 Jul; 6():51. PubMed ID: 21752287
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous malignant peripheral nerve sheath tumors.
Thomas C; Somani N; Owen LG; Malone JC; Billings SD
J Cutan Pathol; 2009 Aug; 36(8):896-900. PubMed ID: 19586501
[TBL] [Abstract][Full Text] [Related]
16. Topical sirolimus as an effective treatment for a deep neurofibroma in a patient with neurofibromatosis type I.
Malhotra N; Levy JMS; Fiorillo L
Pediatr Dermatol; 2019 May; 36(3):360-361. PubMed ID: 30828862
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatosis associated with malignant neurofibromas.
Knight WA; Murphy WK; Gottlieb JA
Arch Dermatol; 1973 May; 107(5):747-50. PubMed ID: 4633999
[No Abstract] [Full Text] [Related]
18. Neoplastic complications of neurofibromatosis.
Pantoja E; Llobet RE; Taveras JE
Cutis; 1978 Dec; 22(6):677-80. PubMed ID: 102488
[TBL] [Abstract][Full Text] [Related]
19. Association of urticaria pigmentosa with café-au-lait spots, neurofibromas and neurofibroma-like neoplasms: a mere coincidence?
Möhrenschlager M; Engst R; Müller-Weihrich S; Spiessl W; Rüdisser K; Weigl LB; Jessberger B; Braun-Falco M; Abeck D; Ring J
Dermatology; 2003; 206(4):297-302. PubMed ID: 12771469
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: a cohort study of 703 patients.
Khosrotehrani K; Bastuji-Garin S; Riccardi VM; Birch P; Friedman JM; Wolkenstein P
Am J Med Genet A; 2005 Jan; 132A(1):49-53. PubMed ID: 15523617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
